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Sympathetic activation in chronic renal failure (CRF) is a major mechanism leading to the progression of renal disease and
hypertension. In the present study, we tested the hypothesis that in CRF increased reactive oxygen species (ROS) production in
the RVLM mediated by enhanced circulating Angiotensin II (Ang II) is an important mechanism leading to hypertension in CRF.
In CRF rats we found an increase in the abundance of p47phox and gp91phox mRNA within the RVLM associated with a reduction
of Ang II type 1 receptors (AT1) mRNA in the brainstem compared to controls (C). Tempol but not candesartan into the RVLM
decreased MAP in CRF but not in C rats. GABA into the RVLM decreased MAP in CRF (63 ±8m m H g )m o r ei n t e n s e l yt h a ni nC
(33 ± 3mmHg). The results suggest that increased oxidative stress within the RVLM has an important participation to maintain
hypertension in CRF rats apparently independently of AT1 Ang II receptors.
1.Introduction
The chronic renal failure (CRF) is characterized by high
circulating Angiotensin II (Ang II) that causes direct
vasoconstriction, increases aldosterone secretion, enhances
sympathetic nerve activity, and increases reactive oxygen
species production (ROS), acting at peripheral and central
sites [1].
There is increasing evidence to support the hypothesis
that ROS play a major role in the pathophysiology of CRF
[2]. In fact, Ang II action in the brain increases the activity
of NAD(P)H oxidase, a major source of superoxide anion
(O2) production [2]. NAD(P)H oxidase is composed of two
membrane-bound subunits (gp91phox and p22phox), several
cytoplasmic units (p40phox,p 4 7 phox,a n dp 6 7 phox), and the
small G protein Racla [3]. After activation of Ang II type
1( A T 1) receptors, the cytoplasmic subunits bind to the
membrane subunits and activate theenzyme, resulting in the
intracellular production of O−
2 [4]. Therefore, the ﬁrst aim
of the present study was to quantify the NADPHp47phox and
gp91phox subunits expression within the RVLM. Considering
that in CRF there is an increase in the brain Ang II, the
expression ofAT1 subtype receptor was also quantiﬁed in the
RVLM.
To functionally test the role of oxidative stress and AT1
receptors on hypertension in CRF rats we injected into
the RVLM the superoxide mimetic-tempol and the AT1
antagonist-candesartan, respectively. Finally, the importance
of RVLM in the maintenance of hypertension in CRF was
evaluated by injection of GABA into the region.
2.Materialsand Methods
2.1. General Procedures. All experimental procedures were
conducted according to the National Institutes of Health
guidelines for use and care of animals, and the study pro-
tocol was approved by the Ethics in Research Committee2 International Journal of Hypertension
Table 1: PCR primer sequences for Real Time quantitative PCR.
Gene Primer Sequence (5  to 3 ) Product size (bp) Annealing Temperature
AT1 5  ATG-CCA-GTG-TGT-TTC-TGC-TC 244 58,0◦C
CCA-ATG-GGG-AGT-GTT-GAG-TT
β-actin 5  CCT-CTA-TGC-CAA-CAC-AGT-GC 191 56,9◦C
ACA-TCT-GCT-GGA-AGG-TGG-AC
gp91phox 5  AGT-GGT-TCG-CAG-ACC-TGC-TG 239 57◦C
TCT-GGT-GTT-GGG-GTG-TTG-AC
p47phox 5  GTC-TGA-GGG-TGA-AGC-CAT-CG 211 59◦C
CCG-AGA-ACG-CTG-GTG-GAT-GC
Angiotensin II type 1 (AT1), β-actin (housekeeping), NAD(P)H subunits(p47phox and gp91phox).
of the Federal University of Sao Paulo School of Medicine
(process no. 0661/04).
Male Wistar rats (n = 55, 250 to 300g) were obtained
from the animal care facility of our institution. The animals
were housed in group cages, given access to rat chow
and water ad libitum, and maintained in a temperature-
controlled environment (23◦C) on a 12-h light/dark cycle.
The drugs urethane (Ethyl carbamate), glutamate,
GABA, tempol, candesartan, hexamethonium, and potassi-
um chloride from Sigma (USA) were all dissolved in saline.
And Xylazine (Sedafarm-Farmabase Sa´ ude Animal Lta-
Brazil), Ketamine (Agener Uni˜ ao-Brazil) were used.
2.2. Experimental Protocols
2.2.1. Hypertensive Animals. The animals were anesthetized
with Ketamine and Xylazine (40 and 20mg/Kg, i.p., resp.),
the right kidney was removed, and the posterior and the
inferior arteries of the left kidney were tied, consequently
leading tothe irrigation ofthe superiorportion ofthe kidney
(5/6 nephrectomy). The control group had sham operation.
The animals were taken to their home cage after the surgery
for recovery, and only after four weeks of the renal surgery
they were instrumented so that the experiments could be
carried out thereafter.
2.2.2. RNA Isolation, Reverse Transcription, and Quantita-
tive Real-Time PCR. Rats were euthanized by decapitation,
brainstem, and cerebellum immediately removed and stored
at −80◦C. Total RNA was puriﬁed from tissue by the phe-
nol and guanidine isothiocyanate-cesium chloride method
using an appropriate kit (Trizol, Life Tecnologies, USA).
Two micrograms of total RNA were treated with DNase
(RQ1 Rnase-Free Dnase, Promega) to prevent genomic
DNA contamination. The RNA pellet was resuspended in
RNase-free water. Reverse transcribed into cDNA by the
addition of a mix containing 0.5mg/mL oligo d(T), 10mM
DTT, 0.5mM dNTPs (Pharmacia Biotech), and 200U of
reverse transcriptase enzyme (SuperScript RT, Gibco-BRL).
Real-time ampliﬁcation was obtained using a GeneAmp
5700 Sequence Detection System SDS (ABI Prism 7700,
Applied Biosystems, CA, USA). Real-time PCR product
accumulation was monitored using the intercalating dye,
SYBRGreen I(MolecularProbesInc.,USA),which exhibitsa
higher ﬂuorescence upon binding of double-stranded DNA.
Relative gene expression was calculated using conditions at
the early stages of PCR, when ampliﬁcation was logarithmic
and, thus, could be correlated to the initial copy number of
gene transcripts. The reactions were cycled 40 times under
the conditions previously determined by conventional PCR.
Fluorescence for each cycle was quantitatively analyzed by
ABI Prism 7700 SDS (Applied Biosystems, CA, USA). At the
end of the PCR, the temperature was increased from 60 to
95◦Ca tar a t eo f2 ◦C/min, and ﬂuorescence was measured
every 15s to construct the melting curve. A nontemplate
control (NTC) was run with each assay. The relative amount
of each mRNA was estimated using a standard curve
constructed from serial dilutions of cDNA including 1/1,
1/10, and 1/100. PCR was performed with primers selective
for AT1 receptor, p47phox,a n dg p 9 1 phox (Table 1). Results of
5 experiments per group are reported as relative expression
normalized with the β-actin housekeeping gene, used as an
endogenous control and expressed in arbitrary units.
2.2.3. Real-Time Data Analysis. The cycle threshold (Ct)
values were subtracted from the Ct value for each gene
(to give
￿Ct values). These values were used to carry out
statisticalcomparisons.Forgraphicalrepresentation,thefold
variation was then determined using the 2−(ΔΔCt) method
according to published protocols [5]a n dm a n u f a c t u r e r ’ s
recommendations. Fold variation was calculated by deter-
mining the diﬀerence in ΔCt values between a chosen
reference and test sample (
￿
￿Ct value) and applying the
2−(ΔΔCt) formula.
2.2.4. Surgical Instrumentation for Acquisition of the Car-
diovascular Parameters. O n ed a yb e f o r et h ee x p e r i m e n t s ,
t h er a t sw e r ea n e s t h e t i z e dw i t hk e t a m i n ea n dx y l a z i n e( 4 0
and 20mg/Kg, i.p., resp.) and instrumented with femoral
venous and arterial catheters, which were constructed from
PE-50 and PE-10 tubing ﬁlled with heparinized saline, for
drug injection and arterial pressure recording, respectively.
Catheters were externalized throughout the nape of the
animal’s neck. After surgery, the rats were returned to their
home cage for recovery. All experiments were performedInternational Journal of Hypertension 3
twenty four hours after the surgery. On the day of the exper-
iment, arterial blood pressure (BP), mean arterial pressure
(MAP), and heart rate (HR) were recorded in awake,
freely moving rats, and animals were then anesthetized very
slowly with urethane (1.2–1.4g/Kg, IV). This procedure was
performed to avoid changes in arterial blood pressure in
relation toconsciousconditionduring theanesthesia admin-
istration. Allanimals were artiﬁcially ventilatedwith oxygen-
enriched air with a respiratory pump. Rectal temperature
was maintained at 37 ± 0.5◦C by a servo-controlled electric
blanket.
The rat was then mounted prone in a stereotaxic frame
with the head mildly ventroﬂexed (bite bar at −11mm).
The occipital bone was opened over the dorsal medulla and
caudal cerebellum, and the dura mater was retracted. The
anesthetic level was tested during the experiments (with-
drawal reﬂexes to noxious pinching), and extra urethane
(0.1–0.5g/Kg, IV) was given when it was needed.
2.2.5. Drug Microinjections. Glass micropipettes of tip diam-
eter of approximately 20μm were used to pressure injected
L-glutamate (monosodium salt, 10nmol/100nL), GABA
50nmol/100nL (Sigma), tempol 2.0nmol/100nL (Fluka
Chemica),candesartan0.25/0.5/1nmol/100nL (AstraH¨ assle
AB-Sweden) into the RVLM. All the solutions were prepared
in normal saline (pH 7.0–7.4). Glutamate and other drugs
were injected in 5 to 10 seconds sequentially in one side
and in the contralateral region; intervals between injection
sides were around of 10 seconds. The pipettes were held in
a vertical position, and the RVLM was located 3mm rostral
to the calamus scriptorius, 1.7-1.8mm lateral to midline, and
3mm deep. Injections sites were marked at the end of the
experiments by subsequently injecting 50 to 100nL of Evans
blue.In three additional experiments, the vehicleforinjected
drugs (saline) was injected into the RVLM as a control
injection.
2.2.6. Histology. At the end of the experiments, animals were
killed by an overdose of urethane. The brain stem was then
removed and ﬁxed by immersion for at least 24h in 10%
paraformaldehyde solution, after which coronal sections
(40μm) were cut on a freezing microtome, and the sections
were mounted on glass slices and stained with neutral red.
Microinjection sites were identiﬁed by deposition of Evans
blue. Figure 1 shows the distribution of the centers of sites
at which glutamate (10nmol/100nL) was injected into the
RVLM. A positive location for the RVLM was considered
whenthedyewasdepositedventraltothenucleusambiguous
and lateral to the inferior olive nucleus.
2.2.7. Statistical Analysis. All values are expressed as mean ±
SD. The changes in MAP and HR responses during RVLM
microinjections were analyzed in intervals of ﬁve seconds
after microinjection in relation to basal condition by paired
and unpaired t-test. The diﬀerences on MAP and HR
RVL
NTS
NA
STN
ION
P
(a) (b)
Figure 1: Typical microinjection site in the RVLM evaluated by
100nL of Evans blue diﬀusion (a) and schematic representation
(b).CSTindicates corticospinaltract; ION:inferiorolivarynucleus;
NA: nucleus ambiguous; NTS: nucleus of the tractus solitari and
STN: spinaltrigeminalnucleus andP,Pyramid.The arrow indicates
nucleus ambiguous.
between C and CRF groups were assessed by one-way analy-
sis of variance (ANOVA) followed by the Student-Newman-
Keuls method. Diﬀerences were considered signiﬁcant at
P<. 05.
3.Resultsand Discussion
3.1. Renal Hypertension. After 4 weeks of renal surgery, there
was a signiﬁcant increase in MAP in renal hypertensive rats
compared to control group (CRF, 166±7mmHg, n = 25; C,
111 ± 3mmHg, n = 30). There was no signiﬁcant change in
heart rate (HR) (CRF, 406 ± 13bpm and C, 403 ±25bpm).
3.2. mRNA Brainstem Expression of AT1 Receptor and Oxida-
tive Stress Markers in CRF and ControlRats. The AT1 mRNA
expression in brainstem tissue was signiﬁcantly decreased in
CRF rats compared to C group (AT1-CRF, 0.16 ± 0.03 and
C, 0.66 ± 0.09AU), as shown in Figure 2(a). According to
the real-time PCR, the level of p47phox and gp91phox gene
expression in the RVLM in the CRF group was signiﬁcantly
higherthanintheCgroup((p47phox-CRF,33.07±5.47andC,
1.13±0.09 AU; P<. 004) and (gp91phox,1 4 .51±1.49 and C,
1.21±0.28AU;P<. 001)),asshowninFigures 2(b) and 2(c).
3.3. Role of Oxidative Stress within the RVLM in Renal
Hypertension Evaluated by Tempol Administration. Tempol
microinjected into the RVLM decreased MAP in CRF rats
(from164±8 to153±8mmHg,n = 6)asshown Figure 3(a).
In control rats, Tempol into the RVLM did not change MAP.
3.4. Role of the AT1 Angiotensin II Subtype Receptors into the
RVLM in Renal Hypertension. The AT1 Ang II antagonist
candesartan was bilaterally microinjected into the RVLM
(0.25/0.5/1.0nmol/100nL) in CRF and C animals. In the
three diﬀerent doses, candesartan signiﬁcantly increased4 International Journal of Hypertension
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Figure 2: Relative amount of mRNA of AT1 in the brainstem
(a) and NAD(P)H subunits (p47phox and gp91phox) ((b) and (c))
compared to mRNA of β-actin of C and CRF groups. ∗P<. 05
diﬀerence in relation to the C.
MAPin both groups, as shown Table 2. The pressor response
to candesartan was fast and short-lasting.
3.5. Eﬀects of Glutamate and GABA Microinjection into the
RVLM in CRF Rats. Bilateral microinjection of glutamate
into the RVLM in CRF increased BP (from 166 ± 7, to
194±8mmHg) (P<. 05) and decreased HR (from 406±13,
to 389 ± 11bpm, P<. 05). The same dose of glutamate
into the RVLM in C rats caused a signiﬁcant and more
Table 2: Values of mean arterial pressure increase (delta of MAP)
in response to Candesartan microinjection into the RVLM in
hypertensive (CRF) and control (C) rats.
MAP (mmHg)
CRF C
Candesartan 0.25nmol (n = 5) 59 ±75 0 ± 4
Candesartan 0.5nmol (n = 5) 57 ±96 2 ± 3
Candesartan 1.0nmol (n = 5) 26 ±56 4 ± 8
intensive increase in MAP (from 111 ± 3 to 158 ± 5mmHg)
(Figure 3(b)). GABA microinjection into the RVLM in CRF
decreased MAP (from 150 ± 5t o8 6± 8mmHg, P<. 05),
accompanied by a signiﬁcant decrease in HR (from 410 ± 13
to 375 ± 17bpm) (Figure 3(c)). The depressor response to
GABA started during microinjection and returned to basal
level approximately 14 ± 1.5 minutes after the injection.
I nc o n t r o ln o r m o t e n s i v er a t s ,t h es a m ed o s eo fG A B A
decreased MAP (from 111 ± 4t o7 7± 4). The depres-
sor response to GABA started during microinjection and
returned to basal level around 6 ± 2.4m i n u t e sa f t e rt h e
injection.
The fall in MAP in response to GABA into the RVLM
was signiﬁcantly larger in CRFcompared toC animals (MAP
63 ± 8a n d3 3± 3mmHg, resp. P<. 05). Hexamethonium
administration caused the same pattern of blood pressure
reduction as observed with GABA, as shown Figure 3(d).
In the present study, we found a reduction in the
mRNA AT1 expression in the brainstem tissue in CRF rats
accompanied by a signiﬁcant increase in the level of p47phox
and gp91phox gene expression in the RVLM compared to C
group. Additionally, tempol but not candesartan into the
RVLM caused a decrease in MAP in CRF rats, suggesting
that oxidative stress is increased in the region probably
independent of AT1 Ang II receptors activation.
CRF is associated with depressed SOD and elevated
NADPH oxidase expression, which can contribute to oxida-
tive stress by increasing superoxide anion. A depression in
SOD expression was reported previously [6]f o rt h es a m e
CRF model that we used, that could be correlated with the
observed diminution in the activity of SOD and catalase
(CAT), which can contribute to oxidative stress by increasing
superoxide anion and hydrogen peroxide generation.
Superoxide derived from NAD(P)H oxidase avidly reacts
with and inactivates NOand, thereby,modulatesitsbioavail-
ability [6]. The availability of biologically active NO in a
given tissue depends not only on the rate of its production,
but also on the rate of its inactivation by superoxide (NO +
O
−
2 ONOO−)[ 7].
The mechanisms by which the increase in ROS in the
RVLM increased blood pressure are not known. These
responses might be mediated by an interaction between
superoxide and NO. Superoxide anions react rapidly with
NO, forming peroxynitrite and decreasing the bioavailability
of NO in the RVLM. This mechanism contributes to the
increase in sympathetic nerve activity and hypertension [8].International Journal of Hypertension 5
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Figure 3: Values of delta of variation of mean arterial pressure (MAP) during bilateral microinjection of tempol (2.0nmol/100nL) (a),
glutamate (10nmol/100nL) (b), GABA (50nmol/100nL) (c), hexamethonium (30mg/kg, IV) (d) into the RVL in the C and CRF groups.
∗P<. 05 diﬀerence in relation to the C.
The involvement of Ang II is believed to decline, whereas
oxidative stress increases during the progression of renovas-
cular hypertension. The administration of an AT1 receptor
blocker indeed reduced the MAP both during the early and
the chronic phase in renovascular hypertension but failed
to improve either the renal hemodynamics or oxygenation
during the early phase. The acute administration of tempol
is more eﬀective in lowering MAP in chronic renovascular
hypertension than blockade of the renin-angiotensin sys-
tem with ARB or angiotensin-converting enzyme (ACE)
inhibitor [9]. In the present study, the increased oxida-
tive stress within the RVLM is probably independent of
AT1 Ang II receptors based on functional and molecular
results.
A previous study described that subtotal nephrectomy
induced a signiﬁcant increase in TBARS of 144% and SOD
activitywassigniﬁcantlydecreasedto55%inthekidney[10].
As the activation of the RVLM neurons increases blood
pressure, mediated by increases in vascular peripheral
resistance, as well as by cardiac contractility and secre-
tion of catecholamines [11, 12] changes in the neuronal
excitability in this region may be a mechanism involved
in the pathophysiology of arterial hypertension. In fact,
electrophysiological studies in spontaneously hypertensive
rats (S H R s )h a v ec o n ﬁ r m e di n c r e a s e si nt h eﬁ r i n gr a t e so f
RVLM barosensitive neurons containing excitatory amino
acids and terminating in the intermediolateral cell column
of the spinal cord, where the preganglionic sympathetic
neurons are located [13, 14].
In the present study we found an increase in the NADPH
subunits in the RVLM and a decrease in MAP in response to
tempol. However, glutamate into the RVLM increased MAP
more intensively in control than in CRF rats. Changes in
the neuronal excitability in response to local alterations in
neurotransmitters may be involved in such response. Indeed
in CRF rats we found a decrease in nNOS expression (data
not shown) within the RVLM that might be responsible for
the reduced RVLM response to glutamate.
Oral administration of GABA in SHR leads to a decrease
in blood pressure accompanied by a decrease in plasma renin
activity. The mediation of this hypotensive eﬀect appears to
involve the renal nerves by a decrease in renal sympathetic
nerve activity [15]. GABA administration ameliorated renal
function (serum urea nitrogen, Cr, and urinary protein)
in nephrectomized rats (5/6) [16]. In the present study,
GABA into the RVLM induced larger decrease in MAP
in CRF rats compared to controls, suggesting that the
sympathetic vasomotor tone is a major mechanism leading
to hypertension. Oxidative stress within the RVLM is one of
the sources of increased RVLM activity.6 International Journal of Hypertension
4.Conclusion
Altogether, the results suggest that the hypertension in CRF
rats is in part mediated by increased oxidative stress in the
RVLM.
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